Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
| Status: | Recruiting |
|---|---|
| Conditions: | Chronic Obstructive Pulmonary Disease |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 100 |
| Updated: | 4/21/2016 |
| Start Date: | September 2013 |
| End Date: | October 2016 |
| Contact: | Hema Ramamurthi |
| Email: | hramamu1@jhu.edu |
| Phone: | 410-502-9558 |
Using mHealth to Respond Early to Acute Exacerbations of COPD in HIV (mREACH)
Investigators propose to develop methods to improve early identification of acute
exacerbations of COPD (AECOPD) among HIV-infected individuals. Investigators hypothesize
that earlier identification of acute exacerbations through in-home monitoring of respiratory
symptoms, lung function and medication usage will allow appropriate intervention to reduce
the morbidity associated with AECOPD. Therefore, the investigators propose using innovative
mobile health (mHealth) applications to Respond Early to Acute exacerbations of COPD in HIV
(mREACH). COPD is a co-morbidity of HIV with growing recognition, but remains greatly
under-recognized among HIV-infected persons. In this application, among HIV-infected
individuals with spirometry-confirmed COPD, investigators will conduct a pilot randomized
trial of mHealth monitoring compared to usual care to reduce the symptom and clinical burden
of AECOPD.
exacerbations of COPD (AECOPD) among HIV-infected individuals. Investigators hypothesize
that earlier identification of acute exacerbations through in-home monitoring of respiratory
symptoms, lung function and medication usage will allow appropriate intervention to reduce
the morbidity associated with AECOPD. Therefore, the investigators propose using innovative
mobile health (mHealth) applications to Respond Early to Acute exacerbations of COPD in HIV
(mREACH). COPD is a co-morbidity of HIV with growing recognition, but remains greatly
under-recognized among HIV-infected persons. In this application, among HIV-infected
individuals with spirometry-confirmed COPD, investigators will conduct a pilot randomized
trial of mHealth monitoring compared to usual care to reduce the symptom and clinical burden
of AECOPD.
Inclusion Criteria:
- HIV infected
- Has an established longitudinal care provider in Baltimore, MD
- Confirmed COPD defined as post-bronchodilator FEV1/FVC<0.70
- Stable residence for duration of 6 month intervention
Exclusion Criteria:
- Age < 18 years
- Unable/unwilling to provide informed consent
- Failure to present to randomization visit
We found this trial at
1
site
Baltimore, Maryland 21287
Principal Investigator: Gregory Kirk, MD, PhD
Phone: 410-502-9558
Click here to add this to my saved trials
